Subcellular Localization of Cyclic Nucleotide Phosphodiesterase Type 10A Variants, and Alteration of the Localization by cAMP-dependent Protein Kinase-dependent Phosphorylation*

Our previous studies have suggested that two phosphodiesterase type 10A (PDE10A) variants, PDE10A1 and PDE10A2 transcripts, are mainly expressed in humans and that PDE10A2 and PDE10A3 transcripts are major variants in rats. In the present study, immunoblot analysis demonstrated that PDE10A proteins, especially PDE10A2, are more abundant in membrane fractions than in cytosolic fractions of rat striatum. Recombinant PDE10A1 and PDE10A3 were produced only in cytosolic fractions of transfected PC12h cells. By contrast, recombinant PDE10A2 was present mainly in membrane fractions. This finding agreed well with the result of subcellular fractionation of PDE10A in rat striatum. Immunocytochemical analysis showed that PDE10A2 was localized in the Golgi apparatus of transfected PC12h cells. PDE10A2 was phosphorylated by cAMP-dependent protein kinase (PKA) at Thr16. Interestingly, recombinant protein of wild-type PDE10A2, but not PDE10A2 mutant with an Ala replacement at Thr16, was distributed to cytosolic fractions by co-transfection with a plasmid encoding the catalytic subunit of PKA. A PDE10A2 mutant with Glu substitution at Thr16, which can be a mimic of phosphorylation, was localized in the cytosolic fractions of transfected PC12h cells. These observations implied that phosphorylation of PDE10A2 at Thr16 by PKA caused alteration of subcellular localization of PDE10A2 from the Golgi apparatus to cytosol. It is hypothesized that cAMP signaling in the Golgi area and the cytosol in neurons is controlled through alteration of subcellular localization of PDE10A brought by activation of PKA in response to intracellular elevations of cAMP.

[1]  M. Conti,et al.  Activation of Phosphodiesterase IV During Desensitization of the A2A Adenosine Receptor‐Mediated Cyclic AMP Response in Rat Pheochromocytoma (PC12) Cells , 1997, Journal of neurochemistry.

[2]  M. Colledge,et al.  AKAPs: from structure to function. , 1999, Trends in cell biology.

[3]  J. Lippincott-Schwartz,et al.  Forskolin inhibits and reverses the effects of brefeldin A on Golgi morphology by a cAMP-independent mechanism , 1991, The Journal of cell biology.

[4]  L. Raymond,et al.  D1 Dopamine Receptor‐Induced Cyclic AMP‐Dependent Protein Kinase Phosphorylation and Potentiation of Striatal Glutamate Receptors , 1999, Journal of neurochemistry.

[5]  D. Maurice,et al.  Phosphorylation-mediated Activation and Translocation of the Cyclic AMP-specific Phosphodiesterase PDE4D3 by Cyclic AMP-dependent Protein Kinase and Mitogen-activated Protein Kinases , 1999, The Journal of Biological Chemistry.

[6]  K. Fujishige,et al.  Cloning and Characterization of a Novel Human Phosphodiesterase That Hydrolyzes Both cAMP and cGMP (PDE10A)* , 1999, The Journal of Biological Chemistry.

[7]  T. Michaeli,et al.  Alternative Splicing of the High Affinity cAMP-Specific Phosphodiesterase (PDE7A) mRNA in Human Skeletal Muscle and Heart* , 1997, The Journal of Biological Chemistry.

[8]  Jerry Lanfear,et al.  Immunohistochemical localization of PDE10A in the rat brain , 2003, Brain Research.

[9]  K. Fujishige,et al.  Characterization and phosphorylation of PDE10A2, a novel alternative splice variant of human phosphodiesterase that hydrolyzes cAMP and cGMP. , 1999, Biochemical and biophysical research communications.

[10]  Angus C Nairn,et al.  The DARPP-32/protein phosphatase-1 cascade: a model for signal integration 1 Published on the World Wide Web on 22 January 1998. 1 , 1998, Brain Research Reviews.

[11]  E. Avvedimento,et al.  Membrane-bound cAMP-dependent Protein Kinase Controls cAMP-induced Differentiation in PC12 Cells* , 1999, The Journal of Biological Chemistry.

[12]  P. Greengard,et al.  A Dopamine/D1 Receptor/Protein Kinase A/Dopamine- and cAMP-Regulated Phosphoprotein (Mr 32 kDa)/Protein Phosphatase-1 Pathway Regulates Dephosphorylation of the NMDA Receptor , 1998, The Journal of Neuroscience.

[13]  L. Langeberg,et al.  mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module , 2001, The EMBO journal.

[14]  I. Diamond,et al.  Ethanol-induced Translocation of cAMP-dependent Protein Kinase to the Nucleus , 1999, The Journal of Biological Chemistry.

[15]  M. Conti,et al.  Phosphorylation and Activation of a cAMP-specific Phosphodiesterase by the cAMP-dependent Protein Kinase , 1995, The Journal of Biological Chemistry.

[16]  K. Fujishige,et al.  Striatum- and testis-specific phosphodiesterase PDE10A isolation and characterization of a rat PDE10A. , 1999, European journal of biochemistry.

[17]  G. Baillie,et al.  The MAP kinase ERK2 inhibits the cyclic AMP‐specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579 , 1999, The EMBO journal.

[18]  J. Beavo,et al.  Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  B. Desbuquois,et al.  Changes in Low-Km cAMP Phosphodiesterase Activity in Liver Golgi Fractions from Hyper- and Hypoinsulinemic Rats , 1988, Diabetes.

[20]  B. Bloch,et al.  D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAS in distinct neuronal populations of the dorsal and ventral striatum , 1995, The Journal of comparative neurology.

[21]  P. Collas,et al.  Phosphodiesterase 4D and Protein Kinase A Type II Constitute a Signaling Unit in the Centrosomal Area* , 2001, The Journal of Biological Chemistry.

[22]  M. Houslay,et al.  Alternative Splicing of cAMP-specific Phosphodiesterase mRNA Transcripts , 1996, The Journal of Biological Chemistry.

[23]  K. Fujishige,et al.  The human phosphodiesterase PDE10A gene , 2000 .

[24]  S. Jin,et al.  Myomegalin Is a Novel Protein of the Golgi/Centrosome That Interacts with a Cyclic Nucleotide Phosphodiesterase* , 2001, The Journal of Biological Chemistry.

[25]  K. Omori,et al.  A Novel Interaction of cGMP-dependent Protein Kinase I with Troponin T* , 1999, The Journal of Biological Chemistry.

[26]  J. Palacios,et al.  Adenosine A2 receptors: Selective localization in the human basal ganglia and alterations with disease , 1991, Neuroscience.

[27]  P. Vandenabeele,et al.  The cAMP-specific phosphodiesterase PDE4A5 is cleaved downstream of its SH3 interaction domain by caspase-3. Consequences for altered intracellular distribution. , 2000, The Journal of biological chemistry.

[28]  I. Diamond,et al.  Ethanol causes translocation of cAMP-dependent protein kinase catalytic subunit to the nucleus. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Beattie,et al.  Identification and characterization of the type-IVA cyclic AMP-specific phosphodiesterase RD1 as a membrane-bound protein expressed in cerebellum. , 1995, The Biochemical journal.

[30]  F. Fouque,et al.  Activation of a cGMP-stimulated cAMP phosphodiesterase by protein kinase C in a liver Golgi-endosomal fraction. , 2001, European journal of biochemistry.

[31]  M. Conti,et al.  Activation of the cAMP-specific Phosphodiesterase PDE4D3 by Phosphorylation , 1999, The Journal of Biological Chemistry.

[32]  Friedrich W. Herberg,et al.  Neurobeachin: A Protein Kinase A-Anchoring,beige/Chediak-Higashi Protein Homolog Implicated in Neuronal Membrane Traffic , 2000, The Journal of Neuroscience.

[33]  H. Hatanaka,et al.  Nerve growth factor-mediated stimulation of tyrosine hydroxylase activity in a clonal rat pheochromocytoma cell line , 1981, Brain Research.

[34]  S. Jin,et al.  Subcellular Localization of Rolipram-sensitive, cAMP-specific Phosphodiesterases , 1998, The Journal of Biological Chemistry.

[35]  J. Beavo,et al.  Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. , 2000, Current opinion in cell biology.

[36]  D. Holberton.  Microtubules in the Cytoplasm of an Amoeba , 1969, Nature.

[37]  Jim Warwicker,et al.  TAPAS-1, a Novel Microdomain within the Unique N-terminal Region of the PDE4A1 cAMP-specific Phosphodiesterase That Allows Rapid, Ca2+-triggered Membrane Association with Selectivity for Interaction with Phosphatidic Acid* , 2002, The Journal of Biological Chemistry.

[38]  K. Fujishige,et al.  Isolation and Characterization of Two Novel Phosphodiesterase PDE11A Variants Showing Unique Structure and Tissue-specific Expression* , 2000, The Journal of Biological Chemistry.

[39]  V. Ferrans,et al.  Membrane Localization of Cyclic Nucleotide Phosphodiesterase 3 (PDE3) , 2000, The Journal of Biological Chemistry.

[40]  M. Hagiwara,et al.  The newly synthesized selective Ca2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells. , 1991, Biochemical and biophysical research communications.

[41]  M. Houslay,et al.  The RACK1 Signaling Scaffold Protein Selectively Interacts with the cAMP-specific Phosphodiesterase PDE4D5 Isoform* , 1999, The Journal of Biological Chemistry.